IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q2 2015 Holdings

Filed 2015-08-14 | 19 holdings | $1.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.1M135,80077.3%
Medivation, Inc.COM58501N101$251.1K2,198,91918.4%
Synthetic Biologics Inc.COM87164U102$9.7K3,400,8160.7%
Ampio Pharmaceuticals Inc.COM03209T109$8.1K3,388,3220.6%
Alcobra LtdSHSM2239P109$7.3K1,115,3150.5%
Abeona Therapeutics Inc(ABEO1EUR)COM00289Y107$6.9K1,359,7670.5%
Advaxis Inc.COM NEW7624208$5.6K275,0000.4%
Corbus Pharmaceuticals Hldgs(CRBPEUR)COM21833P103$5.4K1,750,0000.4%
Newlink Genetics CorpCOM651511107$4.5K102,4370.3%
Bio Blast Pharma LtdSHSM20156101$2.3K338,1100.2%
Keryx Biopharmaceuticals Inc.COM492515101$2.0K200,0000.1%
Caladrius Biosciences IncCOM128058104$1.9K1,000,0000.1%
Advaxis Inc.W EXP 07/15/2017624117$1.7K112,5000.1%
Lion Biotechnologies IncCOM53619R102$89097,1000.1%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$65465,0000.0%
OHR Pharmaceutical IncCOM NEW67778H200$515205,0000.0%
Evoke Pharma IncCOM30049G104$29155,6600.0%
Zosano Pharma CorpCOM98979H103$14520,0000.0%
Aptose Biosciences IncCOM NEW03835T200$10220,0000.0%